Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Extra blood cell manufacturing in two myeloproliferative neoplasms (MPNs) — important thrombocythemia, or ET, and polycythemia vera, also referred to as PV —...
Dr. Andrew M. Evens outlines how individualized, lifelong care is important for adolescent and younger adults with lymphoma as a consequence of social...
